Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil infusion versus epidural analgesia for pain control during vaginal delivery
IRCT20190325043107N14Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in labor pain comparing Continuous intravenous remifentanil with Epidural bupivacaine plus fentanyl (2 arms). Primary endpoint: Pain. Started Jan 2020; status: completed.
02
Drugs
remifentanilbupivacainefentanyl
03
Conditions
labor pain
Beyond the preview
Go deeper on IRCT20190325043107N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N14.